Circadian variation in plasma levels of free-form tissue factor pathway inhibitor antigen in patients with coronary spastic angina

Japanese Circulation Journal

Volumn 62, Issue 6, 1998, Pages 419-424

  Misumi, Kenji ^a   Ogawa, Hisao ^a   Yasue, Hirofumi ^a   Soejima, Hirofumi ^a   Suefuji, Hisakazu ^a   Nishiyama, Koichi ^a   Takazoe, Keiji ^a   Kugiyama, Kiyotaka ^a   Tsuji, Ichiro ^b   Kumeda, Kousuke ^b  

^a KUMAMOTO UNIVERSITY   (Japan)

^b Chemo Sero Therapeutic Research Institute   (Japan)

Author keywords

Circadian variation; Coronary spastic angina; Free form tissue factor pathway inhibitor; Ischemic attack

Indexed keywords

TISSUE FACTOR PATHWAY INHIBITOR;

ADULT; AGED; ANGINA PECTORIS; ARTICLE; BLOOD CHEMISTRY; CIRCADIAN RHYTHM; CLINICAL ARTICLE; CORONARY ARTERY SPASM; FEMALE; HOLTER MONITORING; HUMAN; MALE;

EID: 3042882089     PISSN: 00471828     EISSN: None     Source Type: Journal    
DOI: 10.1253/jcj.62.419     Document Type: Article

References (36)

1. Oliva PB, Potts DE, Pluss RG: Coronary arterial spasm in Printzmetal angina. Documentation by coronary angiography. N Engl J Med 1973; 288: 745-751
2. Yasue H, Touyama M, Kato H, Tanaka S, Akiyama F: Printzmetal's variant form of angina pectoris as a manifestation of alpha-adrenergic receptor-mediated coronary artery spasm. Documentation by coronary arteriography. Am Heart J 1976; 91: 148-155
3. Epstein SE, Palmeri ST: Mechanisms contributing to precipitation of unstable angina and acute myocardial infarction: implications regarding therapy. Am J Cardiol 1984; 54: 1245-1252
4. Fuster V, Chesebro JH: Mechanisms of unstable angina. N Engl J Med 1986; 315: 1023-1025
5. Oliva PB, Breckinridge JC: Arteriographic evidence of coronary arterial spasm in acute myocardial infarction. Circulation 1977; 56: 366-374
6. Maseri A, L'Abbate A, Baroldi G, Chierchia A, Marzilli M, Ballestra AM, et al: Coronary vasospasm as a possible cause of myocardial infarction: A conclusion derived from the study of "preinfarction" angina. N Engl J Med 1978; 299: 1271-1277
7. Sherman CT, Litvack F, Grundfest W, Lee M, Hickey A, Chaux A, et al: Coronary angioscopy in patients with unstable angina pectoris. N Engl J Med 1986; 315: 913-919
8. Roberts WC, Jones AA: Quantification of coronary arterial narrowing at necropsy in acute transmural infarction: analysis and comparison of findings in 27 patients and 22 controls. Circulation 1980; 61: 786-790
9. Uenomachi H, Sonoda M, Miyauchi T, Harubyu N, Nagata H, Miyahara K, et al: Relationship between intracoronary thrombolysis and fibrino-coagulation - special reference to TAT/PIC and FPA/ PIC. Jpn Circ J 1996; 60: 149-156
10. Fitzgerald DJ, Roy L, Catella F, Fitzgerald GA: Platelet activation in unstable coronary disease. N Engl J Med 1986; 315: 983-988
11. Eisenberg PR, Sherman LA, Schectman K, Perez J, Sobel BE, Jaffe AS: Fibrinopeptide A: a marker of coronary thrombosis. Circulation 1985; 71: 912-918
12. Théroux P, Latour JG, Leger-Gauthier C, Lara JD: Fibrinopeptide A and platelet factor levels in unstable angina pectoris. Circulation 1987; 75: 156-162
13. Sakata K, Hoshino T, Yoshida H, Shugino H, Miura F, Takada A: Characteristics of vasospastic angina with exercise-induced ischemia - analysis of parameters of hemostasis and fibrinolysis. Jpn Circ J 1996; 60: 277-284
14. Nilsson IM, Ljungner H, Tengbon L: Two different mechanisms in patients with venous thrombosis and defective fibrinolysis: low concentration of plasminogen activator or increased concentration of plasminogen activator inhibitor. Br Med J 1985; 290: 1453-1455
15. Ogawa H, Yasue H, Oshima S, Okumura K, Matsuyama K, Obata K: Circadian variation of plasma fibrinopeptide A level in patients with variant angina. Circulation 1989; 80: 1617-1626
16. Oshima S, Yasue H, Ogawa H, Okumura K, Matsuyama K: Fibrinopeptide A is released into the coronary circulation after coronary spasm. Circulation 1990; 82: 2222-2225
17. Masuda T, Ogawa H, Miyao Y, Yu Q, Misumi I, Sakamoto T, et al: Circadian variation in fibrinolytic activity in patients with variant angina. Br Heart J 1994; 71: 156-161
18. Yamasaki F, Sato T, Takata J, Chikamori T, Ozawa T, Sasaki M, et al: Sympathetic hyperactivity in patients with vasospastic angina - assessment by spectral analysis of heart rate and arterial pressure variabilities. Jpn Circ J 1996; 60: 10-16
19. Wun TC, Kretzmer KK, Girard TJ, Mletich JP, Broze Jr GJ: Cloning and characterization of a cDNA coding for the lipoprotein-associated coagulation inhibitor shows that it consists of three tandem Kunitz-type inhibitory domains. J Biol Chem 1988; 263: 6001-6004
20. Girard TJ, Warren LA, Novotny WF, Likert KM, Brown SG, Miletich JP, et al: Functional significance of the Kunitz-type inhibitory domains of lipoprotein-associated coagulation inhibitor. Nature 1989; 338: 518-520
21. Kokawa T, Enjyoji K, Kumeda K, Kamikubo Y, Harada-Shiba M, Koh H. et al: Measurement of the free form of TFPI antigen in hyperlipidemia: relationship between free and endothelial cell-associated forms of TFPI. Arterioscler Thromb Vasc Biol 1996; 16: 802-808
22. Kokawa T, Abumiya T, Kimura T, Harada-shiba M, Koh H, Tsushima M, et al: Tissue factor pathway inhibitor activity in human plasma: measurement of lipoprotein-associated and free forms in hyperlipidemia. Arterioscler Thromb Vasc Biol 1995; 15: 504-510
23. Lusnik P, Vonica A, Guérin M, Moreau M, Chapman MJ: Anticoagulant activity of tissue factor pathway inhibitor in human plasma is preferentially associated with dense subspecies of LDL and HDL and with Lp(a). Arterioscler Thromb 1993; 13: 1066-1075
24. Lupu C, Lupu F, Dennehy U, Kakkar VV, Scully MF: Thrombin induces the redistribution and acute release of tissue factor pathway inhibitor from specific granules within human endothelial cells in culture. Arterioscler Thromb Vasc Biol 1995; 15: 2055-2062
25. Novotny WF, Palmier M, Wun T-C, Broze Jr GJ, Miletich JP: Purification and properties of heparin-releasable lipoprotein-associated coagulation inhibitor. Blood 1991; 78: 394-400
26. Abumiya T, Enjyoji K, Kokawa T, Kamikubo Y, Kato H: An anti-tissue factor pathway inhibitor (TFPI) monoclonal antibody recognized the third kunitz domain (K3) of free-form TFPI but not lipoprotein-associated forms in plasma. J Biochem 1995; 118: 178-182
27. Kamei S, Kamikubo Y, Hamuro T, Fujimoto H, Ishihara H, Miyamoto S, et al: amino acid sequence and inhibitory activity of Rhesus Monkey tissue factor pathway inhibitor (TFPI): comparison with human TFPI. J Biochem 1994; 115: 708-714
28. Nishiyama K, Ogawa H, Yasue H, Soejima H, Misumi K, Kugiyama K, et al: Heparin-releasable endothelial cell associated tissue factor pathway inhibitor (TFPI) is increased in the coronary circulation after coronary spasm in patients with coronary spastic angina. Thromb Res (in press)
29. Wagner DD, Olmsted JB, Marder VJ: Immunolocalization of von Willebrand protein in weibel-palade bodies of human endothelial cells. J Cell Biol 1982; 95: 355-360
30. Levin EG, Marzec U, Anderson J, Harker LA: Thrombin stimulates tissue plasminogen activator release from cultured endothelial cells. J Clin Invest 1984; 74: 1988-1995
31. Emeis JJ: Regulation of the acute release of tissue-type plasminogen activator from the endothelium by coagulation activation products. Ann NY Acad Sci 1992; 249-258
32. Kaikita K, Ogawa H, Yasue H, Sakamoto T, Suefuji H, Sumida H, et al: Soluble P-selectin is released into the coronary circulation after coronary spasm. Circulation 1995; 92: 1726-1730
33. Sandset PM, Sirnes PA, Abildgaard U: Factor VII and extrinsic pathway inhibitor in acute coronary disease. Br J Hematol 1989; 72: 391-396
34. Abumiya T, Yamaguchi T, Terasaki T, Kokawa T, Kario T, Kato H: Decreased plasma tissue factor pathway inhibitor activity in ischemic stroke patients. Thromb Haemost 1995; 74: 1050-1054
35. Abendscein DR, Meng YY, Torr-Brown S, Sobel BE: Maintenance of coronary patency after fibrinolysis with tissue factor pathway inhibitor. Circulation 1995; 92: 944-949
36. Haskel EJ, Torr SR, Day KC, Palmier MO, Wun T-C, Sobel BE, Abendschein DR: Prevention of arterial reocclusion after thrombolysis with recombinant lipoprotein-associated coagulation inhibitor. Circulation 1991; 84: 821-827